Aim: The X-ray repair cross-complementing (XRCC) gene polymorphisms influence esophageal carcinogenesis by altering the DNA repair capacity. The present study was designed to screen five single nucleotide polymorphisms (SNPs) of XRCC genes for their susceptibility to esophageal cancer (EC) risk. There is no previous report on these polymorphisms for EC from India, where EC frequency is high. Methods: The present study included 497 subjects (213 EC patients and 284 healthy controls). The polymorphisms were screened using the PCR-RFLP method and allele and genotype distribution were compared using chi-square test. Association analysis was done by haplotype analysis and linkage disequilibrium (LD) analysis. Gene-gene interactions were identified using multifactor dimensionality reduction (MDR). The risk was calculated using binary logistic regression. .042). XRCC2 and XRCC3 polymorphisms were not associated with EC risk. Conclusion: XRCC1 p.Arg399Gln plays a protective role in the development of the EC. The study is the first report from India, providing baseline data about genetic polymorphisms in DNA repair genes XRCC1, XRCC2 and XRCC3 modulating overall EC risk.
Introduction
Esophageal cancer (EC) ranks as the sixth leading cause of death from cancer constituting 7% of all gastrointestinal cancers. 1 In India, EC is the fourth most common cause of deaths related to cancer and the second most common cancer among men and fourth among women. 2 Esophageal carcinogenesis is a complex multistep process with poor prognosis where environmental, geographic and genetic factors appear to play a major role. 3 Cancer is a disease characterized by the failure of DNA repair mechanisms. XRCC1 protein as a part of Base excision repair (BER) pathway plays an efficient role in repairing DNA single-strand breaks. 4 It is encoded by the XRCC1 gene located on 19q13.2, comprising of 17 exons and 16 introns. 5 Two XRCC1 polymorphisms, p.
Arg194Trp (exon 6) and p. Arg280His (exon 9) affect the function of the protein.
6
XRCC1 p.Arg399Gln polymorphism in exon 10 7 has been associated with breast, XRCC2 (chromosome location 7q36.1) plays a major role in Homologous recombination repair (HRR) pathway.
11
XRCC2 p.Arg188His polymorphism located in exon3 12 has been associated with cancers like pancreatic, 13 ovarian, 14 oral 15 and upper aerodigestive tract cancers.
16
XRCC3 (chromosome location 14q32.3) encodes a 346 amino acid polypeptide 17 that participates in DNA doublestrand break repair. Variation in expression of XRCC3 has been reported in various cancers, like gastric, breast, lung, skin and colorectal. [18] [19] [20] [21] The most common polymorphism in XRCC3 p.Thr241Met in exon 7 can influence the ability to repair DNA. 21 Allelic variants of XRCC1, XRCC2, and XRCC3 are associated with risk of different types of cancer among different populations all over the world. [22] [23] [24] In the world's second-most populous country India, the large and diverse ethnic subpopulations 25 need to be studied to understand the genetic basis of several region-specific complex disorders. To the best of our knowledge, studies related to these DNA-repair genes are very few for esophageal cancer in India (Table 1 ). The state of Punjab, India, has very high age-adjusted rate (AAR) for EC; it ranks second in males after prostate cancer and fourth after breast, ovarian and cervical cancer in females in this region. 26, 27 Therefore, the present study was carried out to explore the role of five polymorphisms of XRCC genes; XRCC1 (p.Arg399Gln, p.Arg194Trp, p.Arg280His), XRCC2 (p.Arg188His) and XRCC3 (p.Thr241Met) in the risk of EC in the population of Punjab, India.
Materials and Methods

Study Population and Sample Collection
The present case-control study was conducted after due ethical clearance according to the tenets of the Declaration of Helsinki by the institutional ethics committee of Guru Nanak Dev University, Amritsar. The study sample included 497 subjects: 213 (125 females and 88 males) esophageal cancer patients without a history of any other cancer, any treatment before sample collection and pre-operative from Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar. Complete information including age, gender, lifestyle, diet, family history, and environmental factors were recorded on a proforma after written informed consent from all the subjects. Two hundred eighty-four (187 females and 97 males), age and gender-matched unrelated healthy controls from the same geographical region were also included in the study ( Table 2) .
Collection of Blood samples and genotyping: Intravenous blood sample was collected in EDTA from each subject. Genomic DNA from blood was collected using standard Phenol chloroform method. 28 The PCR products were digested with appropriate restriction endonucleases using manufacturer recommendations (NEB, UK) and analyzed on ethidium bromide stained agarose gel to obtain genotypes based on the size of fragment obtained (Table 3) . To reassure of the quality of the result 10% of the samples were re-genotyped.
Statistical Analysis
Statistical analysis was done using SPSS software version 20 (SPSS, Chicago, IL, USA). The analysis of categorical variables was done using the chi-square test and the continuous independent variables were expressed as mean ± standard deviation using the Student's t-test. Hardy-Weinberg equilibrium was tested using the chi-square test. Binary logistic regression analysis was done to measure the risk of EC with genotypes of selected polymorphisms and the values were adjusted for the possible confounding effect of age, gender, diet, smoking and alcohol consumption. Odds ratios (ORs), p-values and 95% confidence interval (CI) were calculated as the measure of the strength of association of the SNPs and esophageal cancer. Haplotypes and linkage disequilibrium patterns were studied using Haploview software. Furthermore, multifactor dimensionality reduction (MDR) factor analysis version 2 was used to calculate the effect of Gene-gene interactions on esophageal cancer.
Results
The detailed characteristics of 497 subjects (213 EC patients and 284 controls) are given in Table 2 and the allele and genotype frequencies are summarised in Table 4 and Table 5 . All the studied subjects were residents of Punjab, India. The endogamous caste groups were Jatt Sikh, Khatri and Scheduled Caste. The subjects were ethnic Punjabi with Scythian and Caucasian racial admixture. 31 In the present study 5 polymorphisms; XRCC1 (p.Arg399Gln, 
Haplotype and Linkage Disequilibrium Analysis
The haplotype frequencies of three polymorphisms of XRCC1 were examined for their association with EC risk (Table 7) . Based on the measures of linkage disequilibrium (LD), the two polymorphisms of XRCC1gene, p.Arg399Gln and p.Arg194Trp, were in slight LD among EC patients (D ̍́= 0.845, r 2 =0.042) ( Figure 1A ). However, control subjects were not in LD for any of the polymorphism ( Figure 1B ). The haplotype GGT (p.Arg399Gln, p.Arg280His, and p. Arg194Trp) was predominant in EC cases as compared to controls, but the difference was statistically non-significant (p=0.1). The possible genotype combinations of three studied polymorphisms of XRCC1 were also examined ( Table 8 ). The combinations comprising the AA genotype (p.Arg399Gln) occurred significantly more often in controls than patients, with AA-CC-CC combination associated with significantly decreased risk of EC (OR=0.5, 95% CI=0.29-0.91, p=0.020). Interaction Analysis (MDR) Table 9 summarises the MDR analysis evaluating the results of all possible combinations of the studied polymorphisms. According to MDR analysis, the best MDR model included all the five studied polymorphisms XRCC1 (p.Arg399Gln, p. Arg194Trp, p.Arg280His), XRCC2 (p.Arg188His) and XRCC3 (p.Thr241Met). The model had a testing balance accuracy of 0.4648 and a training balance accuracy of 0.5905 with a maximum cross-validation consistency of 10/10. However, the model was not statistically significant (p=0.9). Figure 2 depicts the interaction map of all genes, based on entropy measures between individual genes showing a redundancy effect.
Discussion
In India, the esophagus is a major cancer site (NCRP 2016) with a majority being Squamous Cell Carcinoma (SCC) and a comparatively less frequency of adenocarcinoma patients. 32, 33 Similarly, the predominant type of EC in our study was SCC (88%) with only 12% adenocarcinoma patients.
In India, the inter-individual differences in susceptibility to cancer due to the genetic polymorphisms in XRCC1 previously found. 34 As 40 In the present study, about 60% of the subjects belonged to Jatt Sikh Caste group but the subgroup analysis based on castes was not done due to unequal distribution of the sa mples. The XRCC1p.Arg399Gln polymorphism is involved in various protein-protein interactions 41 and higher sister chromatid exchanges and DNA adducts. 42 In the present study, we found that A allele and the AA genotype of XRCC1p.Arg399Gln polymorphism was associated with a decreased risk of esophageal cancer. Furthermore, a reduced risk was observed in the recessive model (GG +GAvsAA). When compared with previously reported studies from India, the results of our study were consistent with some studies, especially from North India but contrary to others (Table 1) . Very few studies relating the XRCC1 Arg399Gln polymorphism with esophageal cancer risk are available from which only one is from India. Among previous reports from North India on EC; a study of Chandigarh region 34 found association with a decreased risk of XRCC1 p.Arg399Gln, another study from Uttar Pradesh 43 also reported Arg/Gln (p=0.03, OR= 0.62) and (85) 32 (15) 0 (0) 247 (87) 37 (13 57 and acute myeloid leukemia. 58 However, few studies from South India reported no association of XRCC1p. Arg399Gln polymorphism with any of cancer ( Table 1) .
Results of the present study on XRCC1 p.Arg399Gln polymorphism is in agreement with the studies from different parts of the globe like esophageal cancer in Han Chinese, 59 colorectal adenocarcinoma in Norwegian population, 60 gallbladder cancer, 61 and non-melanoma skin cancers. 62 In contrast, some previous studies have reported the association of Arg399Gln polymorphism with an increased risk of esophageal, 63 stomach and oral cancers, 64 colorectal cancers in Korean, Egyptian and Japanese populations, 65-67 lung cancer 68 and breast cancer. 22 However, three studies did not find any association between p.Arg399Gln polymorphism (85) 32 (15) 0 (0) 247 (87) 37 (13) (82) 38 (18) 0 (0) 232 (81.7) 51 (18) 1(0. .7) 8(3 .7) 178 (62.7) 93 (32.7) 13(4.6) and cancer of the esophagus, 69 gall bladder 70 and breast. 71 We did not observe any significant association of XRCC1p.
Arg194Trp polymorphism with EC risk in the present study. The results were similar to two previous Indian studies. 52, 72 Among international studies, no association of XRCC1 p. Arg194Trp has been reported with EC risk in the population of North Carolina, 73 gastric cancer in Korean population 74 and breast cancer in Caucasian women. 75 On the contrary, Trp allele has been reported to be associated with an increased risk of gastric cancer in the Chinese population.
76
XRCC1 is a protein involved in Base excision repair and efficient repair of DNA single-strand breaks. In the present study, we observed a lower risk of esophageal cancer associated with p.Arg399Gln polymorphism of XRCC1. A relationship between polymorphism in XRCC1Arg399Gln and increased rate of apoptosis has been reported in patients of ulcerative colitis 77 and in schizophrenia patients. 78 The alterations to the DNA repair system could not only suppress it to accomplish the repair process, but it would also become more vulnerable to carry apoptosis and help in wiping out the damaged cells. The increased rates of the apoptosis results into the elimination of potential premalignant cells and hence, the XRCC1 Gln399 may play a protective role in esophageal cancer risk.
The A allele of XRCC1p.Arg280His was associated with an increased risk of esophageal cancer in the present study. Reported studies in different populations and different cancers have contradictory results for this polymorphism. From the North Indian population, p.Arg280His has been associated with an increased risk of hepatocellular carcinoma 46 but no association has been reported with SCC head and neck. 45 From a South Indian population, no significant association with breast cancer risk was reported. 22 A meta-analysis within the Asian population has reported an association of p.Arg280His polymorphism with bladder cancer risk. 79 Another meta-analysis reported the heterozygote and the dominant model to be associated with prostate cancer risk. 80 A allele was associated with an increased risk of adenomas in the Norwegian population.
60
A study on the Chinese population reported no association between p.Arg280His polymorphism and ESCC.
81
XRCC2, an essential protein in the HRR pathway is required for the formation of RAD51 focus, with involvement in tumor progression. 13 No association of XRCC2 p.
Arg188His with EC has been observed in the present study, which is the first report from India for esophageal cancer risk. In previous reports from India, no association of XRCC2 p. Arg188His polymorphism was reported with nasopharyngeal carcinoma 47 whereas another study found an association of GA genotype with increased risk of SCC head and neck. 49 The contradictory reports from different parts of the world have shown that XRCC2 p.Arg188His polymorphism was associated with a significantly increased risk of pharyngeal cancer 16 and breast cancer 12 but not with bladder cancer, 82 23 oral SCC in Thai population, 94 and gastric cancer in the Chinese population. 95 On the other hand, a protective role of CT and TT genotype has been reported in colorectal cancer in Polish population 96 and Basal cell carcinoma of the skin in population from Hungary, Romania and Slovakia. 97 The haplotype analysis in the present study shows an association of haplotype GGT of XRCC1 gene (Arg399-Arg280-194Trp of p.Arg399Gln, p.Arg280His, and p. Arg194Trp polymorphisms) with a risk of EC, however, the association was not statistically significant (Table 7) . Among previous reports from India, a study from Andhra Pradesh (South India) also found no association of any haplotype with Chronic Myeloid Leukemia. 98 However, a study from West Bengal (East India) reported CAG haplotype (Arg194-His280-Arg399) to have reduced risk against gastric cancer. 52 A study from Uttar Pradesh (North India) reported CGA and CAG haplotype of XRCC1 (Arg194-His280-Arg399) to be associated with prostate cancer and haplotype CGA to be associated with bladder cancer. 38 Post radiotherapy in a cancer patient, radiation injury may develop months to years later after treatment, with numerous individual manifestations. The XRCC1 codon 399 Arg/Arg genotype has been associated with increased risk of acute radiation dermatitis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. 99 Hence a patient with the variant AA genotype of 
Conclusion
The present study being the first report from India, providing baseline data about five genetic polymorphisms in three DNA repair genes XRCC1, XRCC2 and XRCC3 modulating overall esophageal cancer susceptibility in ethnic Punjabi Indian subjects. The future utility of this data in screening the population for EC risk is the major strength of the study. The results have also been adjusted for various confounding factors. The limitation is a lack of stratification of subjects on the basis of endogamous caste groups of Punjab due to small cross-sectional sample in individual caste group. A possible interaction between XRCC polymorphisms and environmental factors on cancer risk was investigated in several studies. It is of great interest to evaluate gene-environment interactions to examine the exact roles of genetic polymorphisms in cancer. However, lacking the original data limited our further evaluation of potential gene-environment interactions.
The results suggest a role of XRCC gene polymorphisms in esophageal cancer risk and a need to confirm our findings with higher sample size in different ethnic groups inhabiting different geographical areas of India.
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